making muscle wasting history

Duchenne muscular dystrophy is caused by mutations (genetic mistakes) that disrupt the genetic code of the dystrophin gene. This gene is normally translated by muscle cells into the dystrophin protein, which links the skeleton of the muscle fibers to the protective layer on the outside of fibers. This link stabilizes muscle fibers during muscle contraction (exercise). I like to explain the function of dystrophin using the analogy of an anchor (the skeleton of the muscle) and a boat (the protective layer outside), where dystrophin is the rope that connects the two.
Due to the disruption of the genetic code, only the beginning of the protein can be produced by the cell and the linker function is lost. As a result, Duchenne muscle fibers are very easily damaged, even during normal exercise.
Mutations in the dystrophin gene that do not disrupt the genetic code allow the generation of a dystrophin that is partially functional. These mutations are associated with the less severe Becker muscular dystrophy.

Developing new therapeutic approaches

There are numerous therapeutic approaches and the majority follow the same road of preclinical to clinical studies. First the approach is tested in cultured patient cells, then in animal models of the disease (generally the mdx mouse) and then – when the results in cells and animals are sufficiently convincing, in patients (clinical trials). This part of therapeutic development can take a very long time as often unforeseen hurdles arise, which have to be overcome. Clinical trials are divided in two phases: the early phase trials are primarily done to show that the approach is safe, while in later stage trials the goal is to show that the treatment is efficient as well as safe.

Possible Solutions
Gene Therapy
Cell Therapy
Drug Therapy
Mutation Specific Approach
Increasing Muscle Mass